T cell-B cell interactions in primary immunodeficiencies

Annals of the New York Academy of Sciences

Volumn 1250, Issue 1, 2012, Pages 1-13

  Tangye, Stuart G ^a,b   Deenick, Elissa K ^a,b   Palendira, Umaimainthan ^a,b   Ma, Cindy S ^a,b  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Humoral immunity; Immunodeficiency; T follicular helper cells; T B cell interactions; T dependent B cell activation; XLP

Indexed keywords

B CELL ACTIVATING FACTOR RECEPTOR; CD19 ANTIGEN; CD200 ANTIGEN; CD40 LIGAND; CD81 ANTIGEN; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR5; COMPLEMENT COMPONENT C3D RECEPTOR; DOCK8 PROTEIN; DOCKING PROTEIN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 7 RECEPTOR; L SELECTIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NEUTRALIZING ANTIBODY; OX40 LIGAND; PROTEIN BCL 6; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; STAT3 PROTEIN; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL INTERACTION; CELL LINEAGE; CELL SURVIVAL; CYTOKINE PRODUCTION; CYTOTOXICITY; DENDRITIC CELL; GENE MUTATION; GERMINAL CENTER; HELPER CELL; HUMAN; HUMORAL IMMUNITY; HYPER IGE SYNDROME; HYPER IGM SYNDROME; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INFECTION SENSITIVITY; LOSS OF FUNCTION MUTATION; LYMPHOCYTE DIFFERENTIATION; MEMORY CELL; NONHUMAN; PATHOGENESIS; T LYMPHOCYTE;

EID: 84857497768     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2011.06361.x     Document Type: Article

References (122)

1. Miller, J.F., P.M. De Burgh & G.A. Grant 1965. Thymus and the production of antibody-plaque-forming cells. Nature 208: 1332-1334.
2. Jankovic, B.D., B.H. Waksman & B.G. Arnason 1962. Role of the thymus in immune ractions in rats. I. The immunologic response to bovine serum albumin (antibody formation, Arthus reactivity, and delayed hypersensitivity) in rats thymectomized or splenectomized at various times after birth. J. Exp. Med. 116: 159-176.
3. Friedman, H. 1965. Absence of antibody plaque forming cells in spleens of thymectomized mice immunized with sheep erythrocytes. Proc. Soc. Exp. Biol. Med. 118: 1176-1180.
4. Mosmann, T.R. et al 1986. Two types of murine helper T cell clone: I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136: 2348-2357.
5. Murphy, K.M. & S.L. Reiner 2002. The lineage decisions of helper T cells. Nat. Rev. Immunol. 2: 933-944.
6. Deenick, E.K. et al 2011. Regulation of T follicular helper cell formation and function by antigen presenting cells. Curr. Opin. Immunol. 23: 111-118.
7. Weaver, C.T. et al 2007. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25: 821-852.
8. Dong, C. 2008. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat. Rev. Immunol. 8: 337-348.
9. Breitfeld, D. et al 2000. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J. Exp. Med. 192: 1545-1552.
10. Schaerli, P. et al 2000. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J. Exp. Med. 192: 1553-1562.
11. Ansel, K.M. et al 1999. In vivo-activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokines. J. Exp. Med. 190: 1123-1134.
12. Hardtke, S., L. Ohl & R. Forster 2005. Balanced expression of CXCR5 and CCR7 on follicular T helper cells determines their transient positioning to lymph node follicles and is essential for efficient B-cell help. Blood 106: 1924-1931.
13. Haynes, N.M. et al 2007. Role of CXCR5 and CCR7 in follicular Th cell positioning and appearance of a programmed cell death gene-1high germinal center-associated subpopulation. J. Immunol. 179: 5099-5108.
14. Chtanova, T. et al 2004. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J. Immunol. 173: 68-78.
15. Ma, C.S. et al 2009. Early commitment of naive human CD4(+) T cells to the T follicular helper (T(FH)) cell lineage is induced by IL-12. Immunol. Cell. Biol. 87: 590-600.
16. Ma, C.S., K.E. Nichols & S.G. Tangye 2007. Regulation of cellular and humoral immune responses by the SLAM and SAP families of molecules. Annu. Rev. Immunol. 25: 337-379.
17. Cannons, J.L., S.G. Tangye & P.L. Schwartzberg 2011. SLAM family receptors and SAP adaptors in immunity. Annu. Rev. Immunol. 29: 665-705.
18. Ma, C.S. & E.K. Deenick 2011. The role of SAP and SLAM family molecules in the humoral immune response. Ann. N.Y. Acad. Sci. 1217: 32-44.
19. Deenick, E.K. et al 2010. Follicular helper T cell differentiation requires continuous antigen presentation that is independent of unique B cell signaling. Immunity 33: 241-253.
20. Rasheed, A.U. et al 2006. Follicular B helper T cell activity is confined to CXCR5(hi)ICOS(hi) CD4 T cells and is independent of CD57 expression. Eur. J. Immunol. 36: 1892-1903.
21. Banchereau, J. & F. Rousset 1991. Growing human B lymphocytes in the CD40 system. Nature 353: 678-679.
22. Clark, E.A. & P.J. Lane 1991. Regulation of human B-cell activation and adhesion. Annu. Rev. Immunol. 9: 97-127.
23. Banchereau, J. & F. Rousset 1992. Human B lymphocytes: phenotype, proliferation, and differentiation. Adv. Immunol. 52: 125-262.
24. Elgueta, R. et al 2009. Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunol. Rev. 229: 152-172.
25. Van Kooten, C. & J. Banchereau 1996. CD40-CD40 ligand: a multifunctional receptor-ligand pair. Adv. Immunol. 61: 1-77.
26. Pene, J. et al 2004. Cutting edge: IL-21 is a switch factor for the production of IgG1 and IgG3 by human B cells. J. Immunol. 172: 5154-5157.
27. Ettinger, R., S. Kuchen & P.E. Lipsky 2008. The role of IL-21 in regulating B-cell function in health and disease. Immunol. Rev. 223: 60-86.
28. Bryant, V.L. et al 2007. Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5+ T follicular helper cells. J. Immunol. 179: 8180-8190.
29. Avery, D.T. et al 2008. IL-21-induced isotype switching to IgG and IgA by human naive B cells is differentially regulated by IL-4. J. Immunol. 181: 1767-1779.
30. Linterman, M.A. et al 2010. IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses. J. Exp. Med. 207: 353-363.
31. Zotos, D. et al 2010. IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism. J. Exp. Med. 207: 365-378.
32. Ozaki, K. et al 2002. A critical role for IL-21 in regulating immunoglobulin production. Science 298: 1630-1634.
33. King, I.L. & M. Mohrs 2009. IL-4-producing CD4+ T cells in reactive lymph nodes during helminth infection are T follicular helper cells. J. Exp. Med. 206: 1001-1007.
34. Reinhardt, R.L., H.E. Liang & R.M. Locksley 2009. Cytokine-secreting follicular T cells shape the antibody repertoire. Nat. Immunol. 10: 385-393.
35. Yusuf, I. et al 2010. Germinal center T follicular helper cell IL-4 production is dependent on signaling lymphocytic activation molecule receptor (CD150). J. Immunol. 185: 190-202.
36. Zaretsky, A.G. et al 2009. T follicular helper cells differentiate from Th2 cells in response to helminth antigens. J. Exp. Med. 206: 991-999.
37. Morita, R. et al 2011. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 34: 108-121.
38. Bauquet, A.T. et al 2009. The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells. Nat. Immunol. 10: 167-175.
39. Johnston, R.J. et al 2009. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science 325: 1006-1010.
40. Snapper, C.M. & J.J. Mond 1993. Towards a comprehensive view of immunoglobulin class switching. Immunol. Today 14: 15-17.
41. Nurieva, R.I. et al 2008. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 29: 138-149.
42. Suto, A. et al 2008. Development and characterization of IL-21-producing CD4+ T cells. J. Exp. Med. 205: 1369-1379.
43. Eddahri, F. et al 2009. Interleukin-6/STAT3 signaling regulates the ability of naive T cells to acquire B-cell help capacities. Blood 113: 2426-2433.
44. Dienz, O. et al 2009. The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells. J. Exp. Med. 206: 69-78.
45. Vogelzang, A. et al 2008. A fundamental role for interleukin-21 in the generation of T follicular helper cells. Immunity 29: 127-137.
46. Poholek, A.C. et al 2010. In vivo regulation of Bcl6 and T follicular helper cell development. J. Immunol. 185: 313-326.
47. Eto, D. et al 2011. IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation. PLoS One 6: e17739.
48. King, I.L., K. Mohrs & M. Mohrs 2010. A nonredundant role for IL-21 receptor signaling in plasma cell differentiation and protective type 2 immunity against gastrointestinal helminth infection. J. Immunol. 185: 6138-6145.
49. Yi, J.S., M. Du & A.J. Zajac 2009. A vital role for interleukin-21 in the control of a chronic viral infection. Science 324: 1572-1576.
50. Batten, M. et al 2010. IL-27 supports germinal center function by enhancing IL-21 production and the function of T follicular helper cells. J. Exp. Med. 207: 2895-2906.
51. Schmitt, N. et al 2009. Human dendritic cells induce the differentiation of interleukin-21-producing T follicular helper-like cells through interleukin-12. Immunity 31: 158-169.
52. Walker, L.S. et al 1999. Compromised OX40 function in CD28-deficient mice is linked with failure to develop CXC chemokine receptor 5-positive CD4 cells and germinal centers. J. Exp. Med. 190: 1115-1122.
53. Akiba, H. et al 2005. The role of ICOS in the CXCR5+ follicular B helper T cell maintenance in vivo. J. Immunol. 175: 2340-2348.
54. Flynn, S. et al 1998. CD4 T cell cytokine differentiation: the B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1. J. Exp. Med. 188: 297-304.
55. Brocker, T. et al 1999. CD4 T cell traffic control: in vivo evidence that ligation of OX40 on CD4 T cells by OX40-ligand expressed on dendritic cells leads to the accumulation of CD4 T cells in B follicles. Eur. J. Immunol. 29: 1610-1616.
56. Fillatreau, S. & D. Gray 2003. T cell accumulation in B cell follicles is regulated by dendritic cells and is independent of B cell activation. J. Exp. Med. 197: 195-206.
57. Bossaller, L. et al 2006. ICOS deficiency is associated with a severe reduction of CXCR5+CD4 germinal center Th cells. J. Immunol. 177: 4927-4932.
58. Gigoux, M. et al 2009. Inducible costimulator promotes helper T-cell differentiation through phosphoinositide 3-kinase. Proc. Natl. Acad. Sci. USA 106: 20371-20376.
59. Choi, Y.S. et al 2011. ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6. Immunity 34: 932-946.
60. Cannons, J.L. et al 2010. Optimal germinal center responses require a multistage T cell: B cell adhesion process involving integrins, SLAM-associated protein, and CD84. Immunity 32: 253-265.
61. Romero, X. et al 2004. Differential expression of SAP and EAT-2-binding leukocyte cell-surface molecules CD84, CD150 (SLAM), CD229 (Ly9) and CD244 (2B4). Tissue Antigens 64: 132-144.
62. McCausland, M.M. et al 2007. SAP regulation of follicular helper CD4 T cell development and humoral immunity is independent of SLAM and Fyn kinase. J. Immunol. 178: 817-828.
63. Qi, H. et al 2008. SAP-controlled T-B cell interactions underlie germinal centre formation. Nature 455: 764-769.
64. Linterman, M.A. et al 2009. Follicular helper T cells are required for systemic autoimmunity. J. Exp. Med. 206: 561-576.
65. Deenick, E.K. & S.G. Tangye 2008. Immunology: helpful T cells are sticky. Nature 455: 745-747.
66. Conley, M.E. 2009. Genetics of hypogammaglobulinemia: what do we really know? Curr. Opin. Immunol. 21: 466-471.
67. Grimbacher, B. et al 2003. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat. Immunol. 4: 261-268.
68. van Zelm, M.C. et al 2006. An antibody-deficiency syndrome due to mutations in the CD19 gene. N. Engl. J. Med. 354: 1901-1912.
69. Kanegane, H. et al 2007. Novel mutations in a Japanese patient with CD19 deficiency. Genes Immun. 8: 663-670.
70. van Zelm, M.C. et al 2010. CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency. J. Clin. Invest. 120: 1265-1274.
71. Castigli, E. et al 2007. Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat. Genet. 39: 430-431.
72. Castigli, E. et al 2005. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat. Genet. 37: 829-834.
73. Pan-Hammarstrom, Q. et al 2007. Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat. Genet. 39: 429-430.
74. Salzer, U. et al 2009. Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes. Blood 113: 1967-1976.
75. Salzer, U. et al 2005. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat. Genet. 37: 820-828.
76. Warnatz, K. et al 2009. B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans. Proc. Natl. Acad. Sci. USA 106: 13945-13950.
77. Notarangelo, L.D. et al 2009. Primary immunodeficiencies: 2009 update. J. Allergy Clin. Immunol. 124: 1161-1178.
78. Allen, R.C. et al 1993. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259: 990-993.
79. DiSanto, J.P. et al 1993. CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM. Nature 361: 541-543.
80. Korthauer, U. et al 1993. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361: 539-541.
81. Agematsu, K. et al 1998. Absence of IgD-CD27(+) memory B cell population in X-linked hyper-IgM syndrome. J. Clin. Invest. 102: 853-860.
82. Weller, S. et al 2001. CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans. Proc. Natl. Acad. Sci. USA 98: 1166-1170.
83. Weller, S. et al 2004. Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 104: 3647-3654.
84. Facchetti, F. et al 1995. Immunohistologic analysis of ineffective CD40-CD40 ligand interaction in lymphoid tissues from patients with X-linked immunodeficiency with hyper-IgM. Abortive germinal center cell reaction and severe depletion of follicular dendritic cells. J. Immunol. 154: 6624-6633.
85. Ferrari, S. et al 2001. Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc. Natl. Acad. Sci. USA 98: 12614-12619.
86. Doffinger, R. et al 2001. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat. Genet. 27: 277-285.
87. Jain, A. et al 2001. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat. Immunol. 2: 223-228.
88. Jain, A. et al 2004. Specific NEMO mutations impair CD40-mediated c-Rel activation and B cell terminal differentiation. J. Clin. Invest. 114: 1593-1602.
89. Orange, J.S. et al 2004. The presentation and natural history of immunodeficiency caused by nuclear factor kappaB essential modulator mutation. J. Allergy Clin. Immunol. 113: 725-733.
90. Sayos, J. et al 1998. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 395: 462-469.
91. Ochs, H.D. et al 1983. X-linked lymphoproliferative syndrome: abnormal antibody responses to bacteriophage phi X 174. Birth Defects Orig. Artic. Ser. 19: 321-323.
92. Sumegi, J. et al 2000. Correlation of mutations of the SH2D1A gene and Epstein-Barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease. Blood 96: 3118-3125.
93. Ma, C.S. et al 2005. Impaired humoral immunity in X-linked lymphoproliferative disease is associated with defective IL-10 production by CD4+ T cells. J. Clin. Invest. 115: 1049-1059.
94. Ma, C.S. et al 2006. Selective generation of functional somatically mutated IgM+CD27+, but not Ig isotype-switched, memory B cells in X-linked lymphoproliferative disease. J. Clin. Invest. 116: 322-333.
95. Malbran, A. et al 2004. Loss of circulating CD27 + memory B cells and CCR4+ T cells occurring in association with elevated EBV loads in XLP patients surviving primary EBV infection. Blood 103: 1625-1631.
96. Purtilo, D.T. et al 1975. X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet 1: 935-940.
97. Warnatz, K. et al 2006. Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency. Blood 107: 3045-3052.
98. Tangye, S.G. et al 2006. BAFF, APRIL and human B cell disorders. Semin. Immunol. 18: 305-317.
99. Tangye, S.G. 2011. Staying alive: regulation of plasma cell survival. Trends Immunol. 32: 595-602.
100. Holland, S.M. et al 2007. STAT3 mutations in the hyper-IgE syndrome. N. Engl. J. Med. 357: 1608-1619.
101. Minegishi, Y. et al 2007. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 448: 1058-1062.
102. Sheerin, K.A. & R.H. Buckley 1991. Antibody responses to protein, polysaccharide, and phi X174 antigens in the hyperimmunoglobulinemia E (hyper-IgE) syndrome. J. Allergy Clin. Immunol. 87: 803-811.
103. Dreskin, S.C., P.K. Goldsmith & J.I. Gallin 1985. Immunoglobulins in the hyperimmunoglobulin E and recurrent infection (Job's) syndrome. Deficiency of anti-Staphylococcus aureus immunoglobulin. A. J. Clin. Invest. 75: 26-34.
104. Leung, D.Y. et al 1988. Impaired antibody responses in the hyperimmunoglobulin E syndrome. J. Allergy Clin. Immunol. 81: 1082-1087.
105. Avery, D.T. et al 2010. B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans. J. Exp. Med. 207: 155-171.
106. Engelhardt, K.R. et al 2009. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J. Allergy Clin. Immunol. 124: 1289-1302 e1284.
107. Zhang, Q. et al 2009. Combined immunodeficiency associated with DOCK8 mutations. N. Engl. J. Med. 361: 2046-2055.
108. Randall, K.L. et al 2009. Dock8 mutations cripple B cell immunological synapses, germinal centers and long-lived antibody production. Nat. Immunol. 10: 1283-1291.
109. Bittner, T.C. et al 2010. Successful long-term correction of autosomal recessive hyper-IgE syndrome due to DOCK8 deficiency by hematopoietic stem cell transplantation. Klin. Padiatr. 222: 351-355.
110. Conley, M.E. et al 2009. Primary B cell immunodeficiencies: comparisons and contrasts. Annu. Rev. Immunol. 27: 199-227.
111. Mayer, L. et al 1986. Evidence for a defect in "switch" T cells in patients with immunodeficiency and hyperimmunoglobulinemia. M. N. Engl. J. Med. 314: 409-413.
112. Rickert, R.C. 2005. Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex. Curr. Opin. Immunol. 17: 237-243.
113. Tangye, S.G., M.C. Cook & D.A. Fulcher 2009. Insights into the role of STAT3 in human lymphocyte differentiation as revealed by the hyper-IgE syndrome. J. Immunol. 182: 21-28.
114. Fornek, J.L. et al 2006. Critical role for Stat3 in T-dependent terminal differentiation of IgG B cells. Blood 107: 1085-1091.
115. Akira, S. 2000. Roles of STAT3 defined by tissue-specific gene targeting. Oncogene 19: 2607-2611.
116. Speckmann, C. et al 2008. Reduced memory B cells in patients with hyper IgE syndrome. Clin. Immunol. 129: 448-454.
117. Randall, K.L. et al 2011. DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice. J. Exp. Med. 208: 2305-2320.
118. Maecker, H.T. & S. Levy 1997. Normal lymphocyte development but delayed humoral immune response in CD81-null mice. J. Exp. Med. 185: 1505-1510.
119. Hu, H. et al 2011. Noncanonical NF-{kappa}B regulates inducible costimulator (ICOS) ligand expression and T follicular helper cell development. Proc. Natl. Acad. Sci. USA 108: 12827-12832.
120. Hislop, A.D. et al 2007. Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu. Rev. Immunol. 25: 587-617.
121. Hislop, A.D. et al 2010. Impaired Epstein-Barr virus-specific CD8+ T-cell function in X-linked lymphoproliferative disease is restricted to SLAM family-positive B-cell targets. Blood 116: 3249-3257.
122. Palendira, U. et al 2011. Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP. PLoS Biol. 9: e1001187.